50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): HIV, Other Immunodeficiencies And Infections

Sunday, December 7, 2008: 4:30 PM-6:00 PM

Yerba Buena Ballroom Salon 7 (San Francisco Marriott)

Moderators:

Alexandra M. Levine, MD and Erin Reid

4:30 PM

Inhibition of HIV-1 by DpT-Based Iron Chelators

Zufan Debebe¹^*, Krishna Kumar, PhD²^*, Tatiana Ammosova, PhD³^*, Xiaomei Niu, MD¹^*, Des R Richardson, PhD⁴^*, Victor R. Gordeuk, MD⁵ and Sergei Nekhai, PhD¹^*

¹Medicine, Howard University, Washington, DC
²Department of Pharmaceutical Sciences, Howard University, Washington, DC
³Center for Sickle Cell Disease, Howard University, Washington, DC
⁴Children's Cancer Institute, University of New South Wales,, Sydney,, Australia
⁵Howard University, Washington, DC

4:45 PM

Impact of Autologous Dendritic Cell Immunotherapy (Arcelis^TM) on B Cell Subsets in HIV-1-Infected Subjects Receiving Antiretroviral Therapy

Mohamed-Rachid Boulassel¹^*, Bader Yassine-Diab²^*, Don Healey³^*, Charles Nicolette³^*, Rafick-Pierre Sékaly⁴^* and Jean Pierre Routy⁵

¹Division of Hematology, McGill Univeristy Health Centre, Montreal, QC, Canada
²Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada
³Argos Therapeutics Inc, Durham
⁴Chum, INSERM U753 - Université de Montréal, Montréal, Canada
⁵Royal Victoria Hospital, Montreal, QC, Canada

5:00 PM

Generation of vFLIP Transgenic Mice: A Model to Study KSHV-Associated Lymphomagenesis

Gianna Ballon, MD¹^*, Amy Chadburn, MD¹^*, Rocio Perez, MA¹^*, Yi-Fang Liu, MD¹^*, Yoshiteru Sasaki, MD, PhD²^* and Ethel Cesarman, MD, PhD¹

¹Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY
²Laboratory for Stem Cell Biology, RIKEN Center for Developmental Biology, Kobe, Japan

5:15 PM

Panton-Valentine Leukocidin Positive Methicillin Resistant S.Aureus Infections in Children with Cancer

Ashok Srinivasan, M.D.¹^*, Steven Seifried, Ph.D.²^*, Jianmin Pan, PhD³^*, Deo Kumar Srivastava, Ph.D.³^*, Rosalie Perkins⁴^*, W Kim²^*, Pat Flynn, M.D.⁵^*, Gregory Hale, M.D.⁶, Jerry Shenep, M.D.⁵^*, Matthew Bankowski, Ph.D.⁷^* and Randall Hayden, M.D.⁴^*

¹Oncology, St.Jude Children's Research Hospital, Memphis, TN
²Department of Cell and Molecular Microbiology, John A Burns School of Medicine, Honolulu, HI
³Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
⁴Pathology, St.Jude Children's Research Hospital, TN
⁵Infectious Diseases, St.Jude Children's Research Hospital, TN
⁶Oncology, St. Jude Children's Research Hospital, TN
⁷Department of Pathology, John A Burns School of Medicine, Honolulu, HI

5:30 PM

Antibody-Deficiency and Acute Nephritic Syndrome in a Patient with Homozygous Disruption of the CD81 Gene

Menno C van Zelm, PhD¹^*, Julie Smet, MSc²^*, Françoise Mascart, PhD²^*, Brigitte Adams, MD³^*, Liliane Schandené, PhD²^*, Françoise Janssen, MD, PhD³^*, Alina Ferster, MD, PhD⁴, Jacques JM van Dongen, MD, PhD¹ and Mirjam van der Burg, PhD¹^*

¹Dept. Immunology, Erasmus MC, Rotterdam, Netherlands
²Immunobiology Clinic and Laboratory of Vaccinology and Mucosal Immunity, Hôpital Erasme, Bruxelles, Belgium
³Dept. Nephrology, HUDERF, Université Libre de Bruxelles, Bruxelles, Belgium
⁴Hémato-oncologie pédiatrique, Children's University Hospital Reine Fabiola, Brussels, Belgium

5:45 PM

Efficient Induction of HTLV-1-Specific CTL Response by HTLV-1/HBc Chimeric Particle without Adjuvant as a Prophylactic for HTLV-1-Associated T-Cell Leukemia

Tomohiro Kozako, PhD¹^*, Katsuhiko Fukada, PhD²^*, Shinya Hirata, MD, PhD³^*, Michiko Harao, MD, PhD³^*, Yasuharu Nishimura, MD, PhD³^*, Youichiro Kino, PhD²^*, Yohann White, MD⁴^* and Naomichi Arima, MD, PhD⁴

¹Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan
²The Chemo-Sero-Therapeutic Research Institute, Kumamoto, Japan
³Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
⁴Division of Hematology and Immunology, Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Japan

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

202.O1.6 HIV, Other Immunodeficiencies And Infections